Evidence of deregulated cholesterol efflux in abdominal aortic aneurysm

Acta Histochemica

Volumn 118, Issue 2, 2016, Pages 97-108

  Mourmoura, Evanthia ^a   Vasilaki, Anna ^a   Giannoukas, Athanasios ^a   Michalodimitrakis, Emmanouel ^b   Pavlidis, Pavlos ^c   Tsezou, Aspasia ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

ABCA1; Abdominal aortic aneurysm; ApoAI; Cholesterol efflux; LXR; Vimentin

Indexed keywords

ABC TRANSPORTER A1; ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN A1; CARRIER PROTEIN; CD68 ANTIGEN; CHOLESTEROL; CHOLESTEROL EFFLUX RELATED PROTEIN; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; UNCLASSIFIED DRUG; VIMENTIN; ABCA1 PROTEIN, HUMAN; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA ATHEROSCLEROSIS; AORTA INTIMA; AORTA MEDIA; AORTIC TISSUE; ARTICLE; CELL MATURATION; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID STORAGE; MACROPHAGE; MALE; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ABDOMINAL AORTA; ABDOMINAL AORTIC ANEURYSM; ATHEROSCLEROSIS; CASE CONTROL STUDY; CYTOSKELETON; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); SMOOTH MUSCLE CELL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; CASE-CONTROL STUDIES; CHOLESTEROL; CYTOSKELETON; FOAM CELLS; HUMANS; LIPID METABOLISM; LIVER X RECEPTORS; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; ORPHAN NUCLEAR RECEPTORS;

EID: 84960155626     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.11.012     Document Type: Article

References (43)

1. Ahnström J., Gottsäter A., Lindblad B., Dahlbäck B. Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysm. Clin. Biochem. 2010, 43:407-410.
2. Ailawadi G., Moehle C.W., Pei H., Walton S.P., Yang Z., Kron I.L., et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg. 2009, 138:1392-1399.
3. Allahverdian S., Chehroudi A.C., McManus B.M., Abraham T., Francis G.A. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 2014, 129:1551-1559.
4. Allahverdian S., Francis G.A. Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells. Trends Cardiovasc. Med. 2010, 20:96-102.
5. Choi H.Y., Rahmani M., Wong B.W., Allahverdian S., McManus B.M., Pickering J.G., et al. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009, 119:3223-3231.
6. Ciborowski M., Teul J., Martin-Ventura J.L., Egido J., Barbas C. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolomic fingerprint. PLoS ONE 2012, 7:e31982.
7. Cornuz J., Sidoti Pinto C., Tevaearai H., Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur. J. Public Health 2004, 14:343-349.
8. Cuchel M., Rader D.J. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?. Circulation 2006, 113:2548-2555.
9. DiDonato J.A., Huang Y., Aulak K.S., Even-Or O., Gerstenecker G., Gogonea V., et al. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma. Circulation 2013, 128:1644-1655.
10. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:812-819.
11. Edwards P.A., Kennedy M.A., Mak P.A. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vasc. Pharmacol. 2002, 38:249-256.
12. Forsdahl S.H., Singh K., Solberg S., Jacobsen B.K. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø study, 1994-2001. Circulation 2009, 119:2202-2208.
13. Golledge J., van Bockxmeer F., Jamrozik K., McCann M., Norman P.E. Association between serum lipoproteins and abdominal aortic aneurysm. Am. J. Cardiol. 2010, 105:1480-1484.
14. Hamblin M., Chang L., Zhang H., Yang K., Zhang J., Chen Y.E. Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms. J. Vasc. Surg. 2010, 52:984-993.
15. Hellenthal F.A., Geenen I.L., Teijink J.A., Heeneman S., Schurink G.W. Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc. Pathol. 2009, 18:286-293.
16. Henderson E.L., Geng Y.J., Sukhova G.K., Whittemore A.D., Knox J., Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99:96-104.
17. Hobbs S.D., Claridge M.W., Quick C.R., Day N.E., Bradbury A.W., Wilmink A.B. LDL cholesterol is associated with small abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 2003, 26:618-622.
18. Johnsen S.H., Forsdahl S.H., Singh K., Jacobsen B.K. Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1263-1268.
19. Jürgens G., Chen Q., Esterbauer H., Mair S., Ledinski G., Dinges H.P. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler. Thromb. 1993, 11:1689-1699.
20. Kalyanasundaram A., Elmore J.R., Manazer J.R., Golden A., Franklin D.P., Galt S.W., et al. Simvastatin suppresses exprerimental aortic aneurysm expansion. J. Vasc. Surg. 2006, 43:117-124.
21. Kent K.C. Clinical practice. Abdominal aortic aneurysms. N. Engl. J. Med. 2014, 371:2101-2108.
22. Kramer C.M., Cerilli L.A., Hagspiel K., DiMaria J.M., Epstein F.H., Kern J.A. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation 2004, 109:1016-1021.
23. Larsson E., Granath F., Swedenborg J., Hultgran R. A population-based case-control study of the familial risk of abdominal aortic aneurysm. J. Vasc. Surg. 2009, 49:47-50.
24. Liao S., Curci J.A., Kelley B.J., Sicard G.A., Thompson R.W. Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms compared to the adjacent inferior mesenteric artery. J. Surg. Res. 2000, 92:85-95.
25. Lindholt J.S., Heegaard N.H., Vammen S., Fasting H., Henneberg E.W., Heickendorff L. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidized LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 2001, 21:51-56.
26. López-Candales A., Holmes D.R., Liao S., Scott M.J., Wickline S.A., Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysm. Am. J. Pathol. 1997, 150:993-1007.
27. Mackness B., Hunt R., Durrington P.N., Mackness M.I. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997, 30:1233-1238.
28. Ohashi R., Mu H., Wang X., Yao Q., Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005, 98:845-856.
29. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
30. Papathanasiou I., Malizos K.N., Tsezou A. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res. Ther. 2012, 14:R82.
31. Rensen S.S., Doevendans P.A., van Eys G.J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 2007, 15:100-108.
32. Riches K., Angelini T.G., Mudhar G.S., Kaye J., Clark E., Bailey M.A., et al. Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm. J. Trans. Med. 2013, 11:208.
33. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:188-197.
34. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007, 39:86-93.
35. Shimizu K., Shichiri M., Libby P., Lee R.T., Mitchell R.N. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J. Clin. Invest. 2004, 114:300-308.
36. Simoni G., Gianotti A., Ardia A., Baiardi A., Galleano R., Civalleri D. Screening study of abdominal aortic aneurysm in a general population: lipid parameters. Cardiovasc. Surg. 1996, 4:445-448.
37. Soumian S., Gibbs R., Davies A., Albrecht C. mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease. J. Clin. Pathol. 2005, 58:1255-1260.
38. Stary H.C., Chandler A.B., Glagov S., Guyton J.R., Insull W., Rosenfeld M.E., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Counsil on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. 1994, 14:840-856.
39. Tanaka H., Zaima N., Sasaki T., Hayasaka T., Goto-Inoue N., Onoue K., et al. Adventitial vasa vasorum arteriosclerosis in abdominal aortic aneurysm. PLoS ONE 2013, 8:e57398.
40. Vasilaki A., Gardette R., Epelbaum J., Thermos K. NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Invest. Ophthalmol. Vis. Sci. 2001, 42:1600-1609.
41. Vukovic I., Arsenijevic N., Lackovic V., Todorovic V. The origin and differentiation potential of smooth muscle cells in coronary atherosclerosis. Exp. Clin. Cardiol. 2006, 11:123-128.
42. Yu X.H., Fu Y.C., Zhang D.W., Yink K., Tang C.K. Foam cells in atherosclerosis. Clin. Chim. Acta 2013, 424:245-252.
43. Zarins C.K., Xu C., Glaqov S. Atherosclerotic enlargement of the human abdominal aorta. Atherosclerosis 2001, 155:157-164.